FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:516 February 17, 1994 Number 7 Next

Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by The GUSTO Angiographic Investigators

The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial Infarction . In the appendix on page 1621, Centre Hospitalier Universitaire, Grenoble, should have been listed as a collaborating center, and J. Machecourt and B. Bertrand as the participating investigators at that center.

This article has been cited by other articles:

• Antman, A.M., de Lemos, J.A., Braunwald, E. (2001). Epicardial flow and myocardial reperfusion following abciximab and low-dose thrombolytic therapy for acute myocardial infarction. Eur Heart J Suppl 3: A8-A13 [Abstract]  
• Armstrong, P. W., Granger, C., Van de Werf, F. (2001). Bolus Fibrinolysis : Risk, Benefit, and Opportunities. Circulation 103: 1171-1173 [Full Text]  
• White, H. D., Van de Werf, F. J. J. (1998). Thrombolysis for Acute Myocardial Infarction. Circulation 97: 1632-1646 [Abstract] [Full Text]  
• White, H. D., Aylward, P. E., Frey, M. J., Adgey, A. A. J., Nair, R., Hillis, W. S., Shalev, Y., Brown, M. A., French, J. K., Collins, R., Maraganore, J., Adelman, B. (1997). Randomized, Double-blind Comparison of Hirulog Versus Heparin in Patients Receiving Streptokinase and Aspirin for Acute Myocardial Infarction (HERO). Circulation 96: 2155-2161 [Abstract] [Full Text]